EUGENI LÓPEZ BONET

Projectes

Enfermedades Digestivas y Microbiota

Analysis of microbiota patterns linked to pancreatic cancer and their role in host inflammation, oxidative stress, and immune status.

Codi oficial: La Marató 201912-31 Data inicio:30/09/2020 Data fi: 31/01/2024 Investigador/a principal: XAVIER ALDEGUER MANTE Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 199,812.50 €

Enfermedades Digestivas y Microbiota

IMplementación de un PROtocolo de anastomosis colorrectal SegurA IMPROSA

Codi oficial: IMPROSA Data inicio:01/04/2022 Data fi: 30/06/2023 Investigador/a principal: ERNESTO BARZOLA NAVARRO Organisme finançador: F. ASOC. ESP. COLOPROCTOLOGIA Ajuda: 6,600 €

Publicacions

Metabolismo y Cáncer , Cirurgía General y Digestiva , Nutrición, Eumetabolismo y Salud

Prognostic significance of the microbiome-adipose tissue axis in rectal cancer: protocol of a prospective observational study

BJS Open, 2022, 6 dx.doi.org/10.1093/bjsopen/zrac009

Metabolismo y Cáncer

Temprana-Salvador J, López-García P, Castellví Vives J, de Haro L, Ballesta E, Rojas Abusleme M, Arrufat M, Marques F, Casas JR, Gallego C, Pons L, Mate JL, Fernández PL, López-Bonet E, Bosch R, Martínez S, Ramón Y Cajal S, Matias-Guiu X

DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.

Diagnostics, 2022, 12 dx.doi.org/10.3390/diagnostics12040852

Metabolismo y Cáncer , Epidemiología descriptiva, genética y prevención del cáncer , Oncología de Precisión de Girona

Bosch-Barrera J, Verdura S, Ruffinelli JC, Carcereny E, Sais E, Cuyàs E, Palmero R, Lopez-Bonet E, Hernández-Martínez A, Oliveras G, Buxó M, Izquierdo A, Morán T, Nadal E, Menendez JA

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

Cancers, 2021, 13 dx.doi.org/10.3390/cancers13164168

Epidemiología descriptiva, genética y prevención del cáncer , Metabolismo y Cáncer , Oncología de Precisión de Girona

Sanvisens A, Puigdemont M, Rubió-Casadevall J, Vidal-Vila A, López-Bonet E, Martín-Romero F, Marcos-Gragera R

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 dx.doi.org/10.3390/ijerph182413269

Metabolismo y Cáncer , Oncología de Precisión de Girona

Verdura S, Cuyàs E, Cortada E, Brunet J, Lopez-Bonet E, Martin-Castillo B, Bosch-Barrera J, Encinar JA, Menendez JA

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

Aging-Us, 2020, 12, 8-34 dx.doi.org/10.18632/aging.102646

Metabolismo y Cáncer , Oncología de Precisión de Girona

Lopez-Bonet E, Buxó M, Cuyàs E, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Oliveras G, Meléndez C, Castillo L, Verdura S, Brunet J, Joven J, Garcia M, Saidani S, Martin-Castillo B, Menendez JA

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

Journal of Clinical Medicine, 2019, 8 dx.doi.org/10.3390/jcm8122180

Metabolismo y Cáncer , Oncología de Precisión de Girona

Cuyàs E, Fernández-Arroyo S, Buxó M, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Verdura S, Brunet J, López-Bonet E, Garcia M, Saidani S, Joven J, Martin-Castillo B, Menendez JA

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

Aging-Us, 2019, 11, 2874-2888 dx.doi.org/10.18632/aging.101960

Metabolismo y Cáncer , Oncología de Precisión de Girona

Cuyàs E, Buxó M, Ferri Iglesias MJ, Verdura S, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Joven J, Brunet J, López-Bonet E, Garcia M, Saidani S, Queralt Moles X, Martin-Castillo B, Menendez JA

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

Frontiers in oncology, 2019, 9, 193-193 dx.doi.org/10.3389/fonc.2019.00193

Metabolismo y Cáncer , Oncología de Precisión de Girona

Martin-Castillo B, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Stradella A, Morilla I, Viñas G, Cortés J, Cuyàs E, Verdura S, Fernández-Ochoa Á, Fernández-Arroyo S, Segura-Carretero A, Joven J, Pérez E, Bosch N, Garcia M, López-Bonet E, Saidani S, Buxó M, Menendez JA

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study.

Oncotarget, 2018, 9, 35687-35704 dx.doi.org/10.18632/oncotarget.26286

Metabolismo y Cáncer , Cirurgía General y Digestiva , Oncología de Precisión de Girona , Oncología Radioterápica y Física Médica de Girona

Puig-Costa M, Codina-Cazador A, Cortés-Pastoret E, Oliveras-Ferraros C, Cufí S, Flaquer S, Llopis-Puigmarti F, Pujol-Amado E, Corominas-Faja B, Cuyàs E, Ortiz R, Lopez-Bonet E, Queralt B, Guardeño R, Martin-Castillo B, Roig J, Joven J, Menendez JA

Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics.

Oncotarget, 2014, 5, 1942-1954 dx.doi.org/10.18632/oncotarget.1879

12 3 4

Directori

Projectes

Publicacions

Prognostic significance of the microbiome-adipose tissue axis in rectal cancer: protocol of a prospective observational study

DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study.

Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics.

Formulari de contacte

Conoce el IDIBGI!